Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00167323 · ClinicalTrials.gov registry record · NA

Early Recovery Adherence Therapy for Bipolar Alcoholics

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT00167323 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 48 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00167323, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

Effective psychosocial interventions for individuals with an alcohol use disorder co-occurring with a severe mental health problem such as bipolar disorder are lacking. Treatment engagement, adherence, and retention are a major challenge and crucial to achieving a favorable outcome. The early phase of recovery is a key period during which an effective intervention exerts its most significant impact. Our proposed treatment intervention is aimed at addressing early recovery issues, engagement, and treatment and medication adherence in bipolar alcoholics. We propose to develop and refine a theoretically based and procedurally specified individual adherence therapy intervention for co-occurring alcohol use and bipolar disorder in early recovery, to develop standardized procedures, methods, and techniques so that treatment is delivered with a high degree of fidelity and competence, and to test the efficacy of this intervention through a randomized, parallel-group design comparing this new intervention with current regular clinical care.

Interventions

  • BEHAVIORAL Adherence therapy

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2003-07
Est. Completion 2007-07
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT00167323

The ClinicalTrials.gov registry entry for NCT00167323 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Adherence therapy is the first listed.

NCT00167323 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00167323 about?

NCT00167323 is a clinical study titled "Early Recovery Adherence Therapy for Bipolar Alcoholics". Effective psychosocial interventions for individuals with an alcohol use disorder co-occurring with a severe mental health problem such as bipolar disorder are lacking. Treatment engagement, adherence, and retention are a major challenge and crucial to achieving a favorable outcome. The early phase ...

What is the current status of trial NCT00167323?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2003-07. Estimated completion is 2007-07.

What interventions are being tested in trial NCT00167323?

The interventions under investigation include: Adherence therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00167323?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.